Nightingale Health Oyj (FRA:7XE)

Nightingale Health Oyj Ratios and Metrics

Market cap in millions EUR. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	109	158	139	52	109	346
Market Cap Growth	-33.75%	13.71%	164.67%	-51.85%	-68.52%	-
Enterprise Value	61	100	70	-29	7	347
Last Close Price	1.72	2.56	2.00	0.84	1.82	5.25
PS Ratio	23.17	33.63	31.85	12.54	47.09	150.07
PB Ratio	1.64	2.38	1.67	0.54	0.98	2.81
P/TBV Ratio	1.91	2.78	2.00	0.65	1.16	3.11
EV/Sales Ratio	13.02	21.27	16.00	-	3.24	150.35
Debt / Equity Ratio	0.05	0.05	0.03	0.05	0.07	0.09
Asset Turnover	0.06	0.06	0.04	0.04	0.02	0.03
Inventory Turnover	0.94	0.94	2.33	1.03	1.66	0.76
Quick Ratio	8.45	8.45	9.70	12.03	12.17	13.07
Current Ratio	8.80	8.80	9.84	12.14	12.28	13.16
Return on Equity (ROE)	-24.77%	-24.77%	-19.38%	-17.32%	-13.73%	-14.76%
Return on Assets (ROA)	-14.65%	-14.65%	-11.74%	-10.01%	-6.47%	-7.59%
Return on Capital Employed (ROCE)	-28.40%	-28.40%	-22.10%	-18.50%	-11.70%	-7.60%
Earnings Yield	-16.98%	-11.70%	-12.58%	-34.49%	-14.77%	-2.81%
FCF Yield	-11.39%	-7.85%	-7.65%	-15.57%	-8.12%	-0.80%
Buyback Yield / Dilution	-0.01%	-0.01%	-	-0.17%	-44.56%	-22.85%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.